Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
11.63
-0.19 (-1.61%)
At close: Dec 20, 2024, 4:00 PM
11.70
+0.07 (0.60%)
After-hours: Dec 20, 2024, 5:20 PM EST
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for ELAN stock have an average target of 16.75, with a low estimate of 14 and a high estimate of 20. The average target predicts an increase of 44.02% from the current stock price of 11.63.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ELAN stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 6 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +54.77% | Dec 9, 2024 |
| Leerink Partners | Leerink Partners | Hold Initiates $14 | Hold | Initiates | $14 | +20.38% | Dec 2, 2024 |
| Barclays | Barclays | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +71.97% | Nov 8, 2024 |
| Barclays | Barclays | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +63.37% | Oct 28, 2024 |
| Barclays | Barclays | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +89.17% | Sep 23, 2024 |
Financial Forecast
Revenue This Year
4.52B
from 4.42B
Increased by 2.24%
Revenue Next Year
4.65B
from 4.52B
Increased by 2.88%
EPS This Year
0.94
from -2.50
EPS Next Year
0.94
from 0.94
Increased by 0.16%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.7B | 4.9B | 5.2B | |||
| Avg | 4.5B | 4.6B | 4.8B | |||
| Low | 4.3B | 4.4B | 4.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 5.5% | 7.8% | 11.0% | |||
| Avg | 2.2% | 2.9% | 4.3% | |||
| Low | -3.5% | -2.2% | -1.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.00 | 1.05 | 1.26 | |||
| Avg | 0.94 | 0.94 | 1.11 | |||
| Low | 0.89 | 0.81 | 0.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 11.9% | 34.1% | |||
| Avg | - | 0.2% | 17.6% | |||
| Low | - | -13.3% | 4.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.